METABOLIC MARKERS OF INSULIN RESISTANCE IN IRAQI TYPE 2 DIABETES MELLITUS PATIENTS INFECTED WITH H. PYLORI
DOI:
https://doi.org/10.21272/eumj.2025;13(2):417-423Keywords:
H. pylori, diabetic patients, insulin resistance, triglycerideAbstract
Introduction and Aim: People with diabetes mellitus are typically more vulnerable to long-term infections. On the other hand, reports regarding the connection between type II diabetes and H. pylori infection have been inconsistent. The researchers in this study set out to determine how common Helicobacter pylori infection is among Iraqi diabetics.
Materials and Methods: Enzyme-linked immunosorbent assays (ELISA) were used to assess the levels of physiological markers in blood samples obtained from H. pylori-infected individuals in Iraq. The investigation also included patients with type 2 DM without H. pylori infection, who fulfilled the role of the controls.
Results: Compared to the control group of healthy individuals, blood samples from Iraqi patients with diabetes and H. pylori infection exhibited a statistically significant increase (P < 0.01). Diabetic patients who were additionally infected with H. pylori were found to have a higher risk of insulin resistance, obesity, high levels of low-density lipoprotein (LDL), fasting blood sugar (FBS), C-reactive protein (CRP), cholesterol, triglycerides, and higher body mass index (BMI) compared to those without the infection. The study's findings indicate that there was no significant difference in the severity of insulin resistance between patients with Helicobacter pylori infection and those with diabetic mellitus (DM).
Conclusion: This study investigated the impact of H. pylori infection on metabolic parameters in Iraqi patients with type 2 diabetes. The results showed a significant association between H. pylori infection and elevated levels of HbA1c, fasting blood sugar, and BMI. Additionally, the study found a higher prevalence of H. pylori infection in diabetic patients with a history of smoking. These findings highlight the importance of considering H. pylori infection in the management of type 2 diabetes.
Downloads
References
Goyal R, Jialal I. Diabetes Mellitus Type 2. In: StatPearls. StatPearls Publishing; 2022. PMID: 30020625.
Malek R, Hannat S, Nechadi A, Mekideche FZ, Kaabeche M. Diabetes and Ramadan: A multicenter study in Algerian population. Diabetes Res Clin Pract. 2019 Apr;150:322-330. https://doi.org/10.1016/j.diabres.2019.01.010.
Choi YJ, Chung YS. Type 2 diabetes mellitus and bone fragility: Special focus on bone imaging. Osteoporos Sarcopenia. 2016 Mar; 2(1):20-24. https://doi.org/10.1016/j.ots.2015.12.003.
Picke AK, Campbell G, Napoli N, Hofbauer LC, Rauner M. Update on the impact of type 2 diabetes mellitus on bone metabolism and material properties. Endocr Connect. 2019 Mar 01;8(3):R55-R70. https://doi.org/10.1530/EC-18-0518
Carrillo-Larco RM, Barengo NC, Albitres-Flores L, Bernabe-Ortiz A. The risk of mortality among people with type 2 diabetes in Latin America: A systematic review and meta-analysis of population-based cohort studies. Diabetes Metab Res Rev. 2019 May;35(4):e3139. https://doi.org/10.1002/dmrr.3139
Zhou X, Liu W, Gu M, Zhou H, Zhang G. Helicobacter pylori infection causes hepatic insulin resistance by the c-Jun/miR-203/SOCS3 signaling pathway. J Gastroenterol 2015; 50(10):1027–40. https://doi.org/10.1007/s00535-014-1052-4
Jafarzadeh A1, Rezayati MT, Nemati M. Helicobacter pylori seropositivity in patients with type 2 diabetes mellitus in south-east of Iran. Acta Med Iran 2013; 51(12):892–6.
Simon L, Tornóczky J, Tóth M, Jámbor M, Sudár Z. Campylobacter pylori fertözés jelentösége a gasztroenterologiai és diabetologiai gyakorlatban [The significance of Campylobacter pylori infection in gastroenterologic and diabetic practice]. Orv Hetil. 1989 Jun 18;130(25):1325-9. Hungarian. PMID: 2664637.
Shinohara K, Shoji T, Emoto M, Tahara H, Koyama H, Ishimura E, Miki T, Tabata T, Nishizawa Y. Insulin resistance as an independent predictor of cardiovascular mortality in patients with end-stage renal disease. J Am Soc Nephrol. 2002 Jul;13(7):1894-900. https://doi.org/10.1097/01.asn.0000019900.87535.43. PMID: 12089386.
Aydemir S, Bayraktaroglu T, Sert M, Sokmen C, Atmaca H, Mungan G, Gun BD, Borazan A, Ustundag Y. The effect of Helicobacter pylori on insulin resistance. Dig Dis Sci. 2005 Nov;50(11):2090-3.
Malamug LR, Karnchanasorn R, Samoa R, Chiu KC. The Role of Helicobacter pylori Seropositivity in Insulin Sensitivity, Beta Cell Function, and Abnormal Glucose Tolerance. Scientifica (Cairo). 2014;2014:870165. https://doi.org/10.1155/2014/870165. Epub 2014 Mar 25. PMID: 24790772; PMCID: PMC3984821. https://doi.org/10.1155/2014/870165
Yin J, Li M, Xu L, et al. Insulin resistance determined by Homeostasis Model Assessment (HOMA) and associations with metabolic syndrome among Chinese children and teenagers. Diabetol Metab Syndr 5, 71 (2013). https://doi.org/10.1186/1758-5996-5-71
Mphasha MH, Skaal L, Mothiba TM. Prevalence of overweight and obesity amongst patients with diabetes and their non-diabetic family members in Senwabarwana, Limpopo province, South Africa. S Afr Fam Pract (2004). 2022 May 25;64(1):e1-e7. https://doi.org/10.4102/safp.v64i1.5708
Sengupta S, Jaseem T, Ambalavanan J, Hegde A. Homeostatic Model Assessment-Insulin Resistance (HOMA-IR 2) in Mild Subclinical Hypothyroid Subjects. Indian J Clin Biochem. 2018 Apr;33(2):214-217. https://doi.org/10.1007/s12291-017-0701-8
Holvoet P, Lee DH, Steffes M, et al. Analytical performance and diagnostic accuracy of immunometric assays for the measurement of circulating oxidized LDL. Clin Chem. 2006 Apr;52(4):760-4. https://doi.org/10.1373/clinchem.2005.062858
Ferro A, Morais S, Pelucchi C, et al. Smoking and Helicobacter pylori infection: an individual participant pooled analysis (Stomach Cancer Pooling- StoP Project). Eur J Cancer Prev. 2019 Nov;28(5):390-396. https://doi.org/10.1097/CEJ.0000000000000532
Maluf S, Salgado JV, Cysne DN, et al. Increased Glycated Hemoglobin Levels in Patients With Helicobacter pylori Infection Are Associated With the Grading of Chronic Gastritis. Front Immunol. 2020 Oct 29;11:2121. https://doi.org/10.3389/fimmu.2020.587992
Candelli M, Rigante D, Schiavino A, et al. High reinfection rate of Helicobacter pylori in young type 1 diabetic patients: a three-year follow-up study. Eur Rev Med Pharmacol Sci. 2012;16(11):1468–1472.
Tawfeeq RD, Amin ZA, Nuraddin SM, Jalal A, Baiz SK. Relationship between type II diabetes mellitus and Helicobacter pylori infection in Erbil city. Zanco J Med Sci. 2019 Apr 22;23(1):43-50. https://doi.org/10.15218/zjms.2019.013
Vafaeimanesh J, Parham M, Seyyedmajidi M, Bagherzadeh M. Helicobacter pylori infection and insulin resistance in diabetic and nondiabetic population. Scientific World Journal. 2014;2014:391250. https://doi.org/10.1155/2014/391250
Talebi-Taher M, Mashayekhi M, Hashemi MH, Bahrani V. Helicobacter pylori in diabetic and non-diabetic patients with dyspepsia. Acta Med Iran. 2012;50(5):315–318.
Askar A, Abdallah A, Sedky A, Meghezel E, Mohammed A. Effect of Helicobacter pylori Infection on Insulin Resistance in non-Obese, non-Diabetic Patients. Afro-Egyptian Journal of Infectious and Endemic Diseases, 2021; 11(4): 382-388. https://doi.org/10.21608/ajeid.2021.94710.1227
Temesgen GB, Menon M, Gizaw ST, Yimenu BW, Agidew MM. Evaluation of lipid profile and inflammatory marker in patients with gastric Helicobacter pylori infection, Ethiopia. Int J Gen Med. 2022 Jan 6; 15:271-8. https://doi.org/10.2147/IJGM.S346806
Watanabe J, Hamasaki M, Kotani K. The Effect of Helicobacter pylori Eradication on Lipid Levels: A Meta-Analysis. J Clin Med. 2021 Feb 25;10(5):904. https://doi.org/10.3390/jcm10050904. PMID: 33668848; PMCID: PMC7956592
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Dalal Abd Al-Sattar Asaad Baqey, Raghda Salim Sultan, Rana Hazim Hamoode, Bahaa Abdullah Laftaah Al-Rubaii
This work is licensed under a Creative Commons Attribution 4.0 International License.
ISSN: 
